# Arbutus Biopharma Corp: Form 10-Q/A for the period ended Sep 30, 2016

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: 10-Q/A
- Filed: 2016-12-22
- Accepted by EDGAR: Dec 22, 2016, 14:05 ET
- Period: 2016-09-30
- Accession: 0000912282-16-000926
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000091228216000926/arbutus10qa_122016.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000091228216000926/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000091228216000926/arbutus10qa_122016.htm

Filed Dec 22, 2016.
Source: SEC EDGAR, the filing index for accession 0000912282-16-000926. Last ingested by Listed: Nov 12, 2026, 17:55 ET. No prices; not investment advice.
